Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)

被引：0
作者：
Gwon, H. R. [1 ]
机构：
[1] Yonsei Univ Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
NSCLC; clinical stage; staging accuracy;
D O I：
10.1016/j.jtho.2022.07.924
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP13.01-00
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 50 条
[31]   Treatment Patterns and Clinical Practices of Advanced (Stage IV) Non-Small Cell Lung Cancer (NSCLC) in Europe - A Structured Literature Review [J].
Brodowicz, Thomas ;
Niepel, Daniela ;
Booth, Emma ;
Hernandez, Rohini K. ;
Braileanu, George ;
Cawkwell, Marie ;
Amelio, Justyna .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S676-S676
[32]   Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis [J].
Syaj, S. ;
Akhdar, M. ;
Ababneh, O. ;
Hamouri, S. .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S235-S236
[33]   Accuracy of Clinical and Pathologic Staging of Non-Small Cell Lung Cancer in a Residency Education Program [J].
Almarashda, Mariam J. ;
Deppen, Stephen A. ;
Putnam, Joe B., Jr. .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S431-S431
[34]   Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives [J].
Lavacchi, Daniele ;
Mazzoni, Francesca ;
Giaccone, Giuseppe .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :3187-3198
[35]   Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC) [J].
Belani, C. P. ;
Goss, G. ;
Blumenschein, G., Jr. .
CANCER TREATMENT REVIEWS, 2012, 38 (03) :173-184
[36]   Outcome of Stage IIIb Non-small Cell Lung Cancer (NSCLC) Patients - A Single Tertiary Center Experience [J].
Mehmood, T. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2232-S2232
[37]   Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy [J].
Zhang, Mengzhe ;
Yan, Meng ;
Xiao, Zengtuan ;
Li, Yue ;
Liu, Zuo ;
Zhang, Pengpeng ;
Wang, Xiaofei ;
Zhang, Lianmin ;
Zhang, Zhenfa .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 66 (04)
[38]   Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"? [J].
Galvani, Elena ;
Toffalorio, Francesca ;
Peters, Godefridus J. ;
De Pas, Tommaso ;
Giovannetti, Elisa .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (24) :3863-3874
[39]   The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis [J].
Fang, Rui ;
Zhu, Yong ;
Khadka, Vedbar S. ;
Zhang, Fan ;
Jiang, Bin ;
Deng, Youping .
FRONTIERS IN PHYSIOLOGY, 2018, 9
[40]   Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC) [J].
Schmid, S. ;
Diem, S. ;
Krapf, M. ;
Li, Q. ;
Flatz, L. ;
Leschka, S. ;
Desbiolles, L. ;
Klingbiel, D. ;
Jochum, W. ;
Fruh, M. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2419-S2420
12345